In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
World champion Indian team will play the third T20 on Tuesday to maintain its dominance over Engl
Congress's Bharat Jodi Yatra is in Telangana these days. People are gathering on the journey. On
The new Income Tax Bill, 2025, which is being introduced in the Lok Sabha on February 13, has bee
Voting is being held in Bihar on Friday for four Lok Sabha seats – Gaya, Aurangab
After the Russian attack on Ukraine on 24 February, Western countries announced drastic sanctions
A new revelation has been made in the kidnapping case of actor Mushtaq Khan, who played Sunny Deo
Vladimir Putin will not attend the funeral of Mikhail Gorbachev, know what is the reason
Russian President Vladimir Putin will not attend the funeral of Mikhail Gorbachev, the last Presi
PM Modi, who arrived in Sri Lanka for the first time since 2019 on a three-day visit, was warmly
The torture of winter continues in the country. In many states of the country including North Ind
After the terrorist attack in Pahalgam, Jammu and Kashmir, the central government has called an a
